Michelle Gallaher is an award-winning thought-leader, speaker, advocate, and health technology entrepreneur.
Trialkey, Michelle’s current startup (number 4 announced in June this year), is applying artificial intelligence to improving and predicting clinical trial results.
Commencing in allied health, Michelle’s career spans clinical and administrative roles in public and private health, commercial and executive roles with biotech, pharmaceutical, and medical organisations, as well as and leading a biotech peak-body and influencing legislation and regulation in healthtech.
Michelle moved from the corporate world to found her first startup in 2014, successfully selling that business three years later and going on to found AI health tech company Opyl Ltd in 2019 (ASX:OPL).
The appropriate application of AI in healthcare and the role of ethics and digital leadership in technology development is a key issue that Michelle is renowned for as a champion and advocate.
Michelle is an experienced non-executive director on several boards (Praxis Australia, Cancer Trials Australia, and Medtech Actuator) and is co-founder of not-for-profit advocacy organisation, Women in STEMM Australia.
Michelle is a Victorian Honour Roll for Women inductee, Victorian Telstra Businesswoman and Entrepreneur of the Year, and Westpac’s 200 Businesses of Tomorrow winner.
Michelle has an undergraduate degree in applied science, postgraduate qualifications in business and product management, a Global Executive MBA, is a GAICD and FAIM.
Michelle made an effort to ask carefully crafted questions about our audience, the intention of our event, how we wanted our audience to feel coming out of it, our own business to best under ... keep reading Logicalis Australia Pty Ltd
